5lxp
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
==Human PARP14 (ARTD8), catalytic fragment in complex with inhibitor H5== | ==Human PARP14 (ARTD8), catalytic fragment in complex with inhibitor H5== | ||
| - | <StructureSection load='5lxp' size='340' side='right' caption='[[5lxp]], [[Resolution|resolution]] 2.07Å' scene=''> | + | <StructureSection load='5lxp' size='340' side='right'caption='[[5lxp]], [[Resolution|resolution]] 2.07Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[5lxp]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5LXP OCA]. For a <b>guided tour on the structure components</b> use [http:// | + | <table><tr><td colspan='2'>[[5lxp]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5LXP OCA]. For a <b>guided tour on the structure components</b> use [http://proteopedia.org/fgij/fg.htm?mol=5LXP FirstGlance]. <br> |
| - | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=7AG:~{N}-(3-AMINOCARBONYLPHENYL)-~{N}-[[1-[(2~{R})-2-PHENYLPROPYL]-1,2,3-TRIAZOL-4-YL]METHYL]PENTANEDIAMIDE'>7AG</scene></td></tr> | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=7AG:~{N}-(3-AMINOCARBONYLPHENYL)-~{N}-[[1-[(2~{R})-2-PHENYLPROPYL]-1,2,3-TRIAZOL-4-YL]METHYL]PENTANEDIAMIDE'>7AG</scene></td></tr> |
| + | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">PARP14, BAL2, KIAA1268 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr> | ||
<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/NAD(+)_ADP-ribosyltransferase NAD(+) ADP-ribosyltransferase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.4.2.30 2.4.2.30] </span></td></tr> | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/NAD(+)_ADP-ribosyltransferase NAD(+) ADP-ribosyltransferase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.4.2.30 2.4.2.30] </span></td></tr> | ||
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http:// | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://proteopedia.org/fgij/fg.htm?mol=5lxp FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5lxp OCA], [http://pdbe.org/5lxp PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5lxp RCSB], [http://www.ebi.ac.uk/pdbsum/5lxp PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5lxp ProSAT]</span></td></tr> |
</table> | </table> | ||
== Function == | == Function == | ||
| Line 19: | Line 20: | ||
</div> | </div> | ||
<div class="pdbe-citations 5lxp" style="background-color:#fffaf0;"></div> | <div class="pdbe-citations 5lxp" style="background-color:#fffaf0;"></div> | ||
| + | |||
| + | ==See Also== | ||
| + | *[[Poly(ADP-ribose) polymerase 3D structures|Poly(ADP-ribose) polymerase 3D structures]] | ||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| + | [[Category: Human]] | ||
| + | [[Category: Large Structures]] | ||
[[Category: Karlberg, T]] | [[Category: Karlberg, T]] | ||
[[Category: Schuler, H]] | [[Category: Schuler, H]] | ||
Revision as of 10:53, 12 August 2020
Human PARP14 (ARTD8), catalytic fragment in complex with inhibitor H5
| |||||||||||
